Collins MK - Search Results

1

Generation of interleukin-2-secreting melanoma cell populations from resected metastatic tumors.

Patel PM, Flemming CL, Fisher C, Porter CD, Thomas JM, Gore ME, Collins MK. Patel PM, et al. Among authors: collins mk. Hum Gene Ther. 1994 May;5(5):577-84. doi: 10.1089/hum.1994.5.5-577. Hum Gene Ther. 1994. PMID: 8054375

2

Comparison of the potential therapeutic effects of interleukin 2 or interleukin 4 secretion by a single tumour.

Patel PM, Flemming CL, Russell SJ, McKay IA, MacLennan KA, Box GM, Eccles SA, Collins MK. Patel PM, et al. Among authors: collins mk. Br J Cancer. 1993 Aug;68(2):295-302. doi: 10.1038/bjc.1993.331. Br J Cancer. 1993. PMID: 8347485 Free PMC article.

3

IL-12 stimulation but not B7 expression increases melanoma killing by patient cytotoxic T lymphocytes (CTL).

De Wit D, Flemming CL, Harris JD, Palmer KJ, Moore JS, Gore ME, Collins MK. De Wit D, et al. Among authors: collins mk. Clin Exp Immunol. 1996 Aug;105(2):353-9. doi: 10.1046/j.1365-2249.1996.d01-773.x. Clin Exp Immunol. 1996. PMID: 8706345 Free PMC article.

4

Comparison of efficiency of infection of human gene therapy target cells via four different retroviral receptors.

Porter CD, Collins MK, Tailor CS, Parkar MH, Cosset FL, Weiss RA, Takeuchi Y. Porter CD, et al. Among authors: collins mk. Hum Gene Ther. 1996 May 20;7(8):913-9. doi: 10.1089/hum.1996.7.8-913. Hum Gene Ther. 1996. PMID: 8727505

5

Gene therapy with autologous, interleukin 2-secreting tumor cells in patients with malignant melanoma.

Palmer K, Moore J, Everard M, Harris JD, Rodgers S, Rees RC, Murray AK, Mascari R, Kirkwood J, Riches PG, Fisher C, Thomas JM, Harries M, Johnston SR, Collins MK, Gore ME. Palmer K, et al. Among authors: collins mk. Hum Gene Ther. 1999 May 20;10(8):1261-8. doi: 10.1089/10430349950017941. Hum Gene Ther. 1999. PMID: 10365657 Clinical Trial.

6

Transformation-dependent expression of interleukin genes delivered by a recombinant parvovirus.

Russell SJ, Brandenburger A, Flemming CL, Collins MK, Rommelaere J. Russell SJ, et al. Among authors: collins mk. J Virol. 1992 May;66(5):2821-8. doi: 10.1128/JVI.66.5.2821-2828.1992. J Virol. 1992. PMID: 1560527 Free PMC article.

7

Decreased tumorigenicity of a transplantable rat sarcoma following transfer and expression of an IL-2 cDNA.

Russell SJ, Eccles SA, Flemming CL, Johnson CA, Collins MK. Russell SJ, et al. Among authors: collins mk. Int J Cancer. 1991 Jan 21;47(2):244-51. doi: 10.1002/ijc.2910470213. Int J Cancer. 1991. PMID: 1988368

8

Cytokine gene transfer as a therapeutic strategy.

Patel PM, Flemming CL, Russell SJ, Eccles SA, Collins MK. Patel PM, et al. Among authors: collins mk. J Immunother Emphasis Tumor Immunol. 1993 Nov;14(4):310-3. doi: 10.1097/00002371-199311000-00010. J Immunother Emphasis Tumor Immunol. 1993. PMID: 8280713

9

The role of IL-2 interaction with p75 and p55 receptor molecules in the stimulation of cell proliferation.

Perkins GR, Flemming CL, Kabat D, Collins MK. Perkins GR, et al. Among authors: collins mk. Int Immunol. 1993 May;5(5):541-9. doi: 10.1093/intimm/5.5.541. Int Immunol. 1993. PMID: 8318457

10

Mutation of Asp20 of human interleukin-2 reveals a dual role of the p55 alpha chain of the interleukin-2 receptor.

Flemming CL, Russell SJ, Collins MK. Flemming CL, et al. Among authors: collins mk. Eur J Immunol. 1993 Apr;23(4):917-21. doi: 10.1002/eji.1830230423. Eur J Immunol. 1993. PMID: 8458377

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

213 results

Search Page

Filters